These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7620115)

  • 21. Duodenal ulcer treated with omeprazole: healing and relapse rates. Does treatment duration influence subsequent remission?
    Farup PG; Rosseland AR; Halvorsen L; Andersen OK; Bernklev T
    Scand J Gastroenterol; 1989 Nov; 24(9):1107-12. PubMed ID: 2688070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer.
    Beker JA; Bianchi Porro G; Bigard MA; Delle Fave G; Devis G; Gouerou H; Maier C
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):407-10. PubMed ID: 7614102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Solo Investigator Group.
    Bate CM; Booth SN; Crowe JP; Mountford RA; Keeling PW; Hepworth-Jones B; Taylor MD; Richardson PD
    Gut; 1995 Apr; 36(4):492-8. PubMed ID: 7737552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation: randomized controlled trial.
    Ng EK; Lam YH; Sung JJ; Yung MY; To KF; Chan AC; Lee DW; Law BK; Lau JY; Ling TK; Lau WY; Chung SC
    Ann Surg; 2000 Feb; 231(2):153-8. PubMed ID: 10674604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic versus maintenance therapy in the prevention of duodenal ulcer recurrence. Results of a multicentric double-blind randomized trial.
    Sobhani I; Chastang C; De Korwin JD; Lamouliatte H; Mégraud F; Guerre J; Elouaer-Blanc L
    Gastroenterol Clin Biol; 1995 Mar; 19(3):252-8. PubMed ID: 7781936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence.
    Bianchi Porro G; Lazzaroni M; Bargiggia S; Maconi G; Trespi E; Perego M; Alvisi C; Villani L; Luinetti O; Fiocca R; Franceschi M; Cesana B; Solcia E
    Am J Gastroenterol; 1996 Apr; 91(4):695-700. PubMed ID: 8677931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Omeprazole and ranitidine in long-term treatment of duodenal ulcer: a double-blind comparison of length of time in remission.
    Diaz de Rojas F; Berenguer J; Rodrigo L; Aran-Suau R; Da Silveira JC; Clerch L; Garcia Aparicio P; Caswell C
    Dig Dis Sci; 1998 Sep; 43(9):1964-9. PubMed ID: 9753259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pharmacodynamic study of two omeprazole regimens suitable for long-term treatment of duodenal ulcer.
    Vigneri S; Savarino V; Mela GS; Termini R; Di Mario F; Pantalena M; Zentilin P; Muratore F; Scialabba A; Badalamenti S
    Scand J Gastroenterol; 1994 Jun; 29(6):488-92. PubMed ID: 8079104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety.
    Johnson DA; Benjamin SB; Vakil NB; Goldstein JL; Lamet M; Whipple J; Damico D; Hamelin B
    Am J Gastroenterol; 2001 Jan; 96(1):27-34. PubMed ID: 11197282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omeprazole and ranitidine in the prevention of relapse in patients with duodenal ulcer disease.
    Lauritsen K; Rutgersson K; Bolling E; Brunner G; Eriksson S; Galmiche JP; Walan A; Archambault AP; Gudjónsson H; Bailey RJ; Bianchi Porro G; Frison L; Havu N; Thompson AB
    Can J Gastroenterol; 1999 Dec; 13(10):806-13. PubMed ID: 10625320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relapse prevention of duodenal ulcers with trimipramine, cimetidine, or placebo. A double-blind comparison.
    Becker U; Faurschou P; Jensen J; Lindorff K; Pedersen PB; Ranløv PJ
    Scand J Gastroenterol; 1984 May; 19(3):405-10. PubMed ID: 6377466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erosive oesophagitis: outcome of repeated long term maintenance treatment with low dose omeprazole 10 mg or placebo.
    Bardhan KD; Cherian P; Vaishnavi A; Jones RB; Thompson M; Morris P; Brooks A; D'Silva J; Gillon KR; Wason C; Patterson J; Polak J; Bishop A
    Gut; 1998 Oct; 43(4):458-64. PubMed ID: 9824569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double-blind, randomized trial.
    Bell GD; Bate CM; Axon AT; Tildesley G; Kerr GD; Green JR; Emmas CE; Taylor MD
    Aliment Pharmacol Ther; 1995 Oct; 9(5):513-20. PubMed ID: 8580271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer.
    Van Deventer GM; Elashoff JD; Reedy TJ; Schneidman D; Walsh JH
    N Engl J Med; 1989 Apr; 320(17):1113-9. PubMed ID: 2651924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
    Russo A; Dattilo M
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of the cost of maintenance therapy (6 months) with 150 mg ranitidine vs 20 mg omeprazole vs 20 mg omeprazole every other day in duodenal ulcer].
    Di Mario F; Grasso GA; Battaglia G; De Boni M; Vianello F; De Bona M; Pasquino M; Chiozzini G; Saggioro A
    Minerva Gastroenterol Dietol; 1993 Jun; 39(2):83-7. PubMed ID: 8364105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress in prophylaxis against nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee.
    Hawkey CJ
    Am J Med; 1998 Mar; 104(3A):67S-74S; discussion 79S-80S. PubMed ID: 9572324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maintenance therapy with sucralfate in duodenal ulcer: genuine prevention or accelerated healing of ulcer recurrence?
    Bynum TE; Koch GG
    Am J Med; 1991 Aug; 91(2A):84S-90S. PubMed ID: 1882909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of three doses of lansoprazole (15, 30 and 60 mg) and placebo in the treatment of duodenal ulcer. The Lansoprazole Study Group.
    Avner DL; Dorsch ER; Jennings DE; Greski-Rose PA
    Aliment Pharmacol Ther; 1995 Oct; 9(5):521-8. PubMed ID: 8580272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.